HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Bakker, E. Search for Related Content PubMed PubMed Citation Articles by Bakker, E. Related Collections Molecular Diagnostics and Genetics

Is the DNA Sequence the Gold Standard in Genetic Testing? Quality of Molecular Genetic Tests Assessed

Center for Human and Clinical Genetics Leiden University Medical Center PO Box 9600 Leiden, 2300 RC, The Netherlands

The first 20% of the full text of this article appears below.

Molecular genetic testing is a fast-growing diagnostic discipline. Only a few decades have passed since Kan and Dozy (1) described the first DNA test, which used a restriction enzyme digestion to test for sickle cell disease, and my group (2) reported the first use of linked DNA markers for first-trimester prenatal diagnosis of Duchenne muscular dystrophy. Since then, molecular genetic testing with direct or indirect mutation detection has been widely applied to confirm the clinical diagnosis for many monogenetic disorders and to determine carrier status. It also has been applied to predict presymptomatic cases and to predict, early in pregnancy, whether a fetus will be affected with a severe disorder.

Because the complete human genome (sequence) became available in 2003, molecular genetic testing will be applied more widely every day. Risk assessments for multifactorial disorders will gain more attention, as will predictions of genotypes that increase the possibility of adverse outcomes when certain drugs are used (pharmacogenomics).

Genetic information usually does not change throughout an individual’s life; therefore, the sequence of a gene need be determined only once in a person’s lifetime. For this reason, the outcome of a genetic test should be unambiguous, time resistant, and universal in nomenclature. The "DNA sequence of a gene" or "of a gene region" is often perceived as the ultimate result of a molecular genetic test. If we consider the nucleotide (A, T, G, or C) as the "SI unit" for DNA, then a nucleotide sequence comes as close to a gold standard as one can get in terms of a genetic . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				K. S. Lim, R. K. Naviaux, S. Wong, and R. H. Haas Pitfalls in the Denaturing High-Performance Liquid Chromatography Analysis of Mitochondrial DNA Mutation J. Mol. Diagn., January 1, 2008; 10(1): 102 - 108. [Abstract] [Full Text] [PDF]